E. Bollschweiler

512 total citations
23 papers, 357 citations indexed

About

E. Bollschweiler is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, E. Bollschweiler has authored 23 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in E. Bollschweiler's work include Gastric Cancer Management and Outcomes (8 papers), Esophageal Cancer Research and Treatment (6 papers) and Clinical practice guidelines implementation (4 papers). E. Bollschweiler is often cited by papers focused on Gastric Cancer Management and Outcomes (8 papers), Esophageal Cancer Research and Treatment (6 papers) and Clinical practice guidelines implementation (4 papers). E. Bollschweiler collaborates with scholars based in Germany, Switzerland and Austria. E. Bollschweiler's co-authors include Daniel Vallböhmer, A. H. Hölscher, Uta Drebber, Arnulf H. Hölscher, M. Hölscher, Marc Bludau, Stephan Baldus, Dirk L. Stippel, Wolfgang Schröder and Ralf Metzger and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Surgery and Annals of Oncology.

In The Last Decade

E. Bollschweiler

22 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Bollschweiler Germany 9 296 253 77 46 29 23 357
Marta Bini Italy 6 235 0.8× 174 0.7× 32 0.4× 44 1.0× 28 1.0× 18 265
In Seok Choi South Korea 11 270 0.9× 204 0.8× 19 0.2× 114 2.5× 22 0.8× 59 355
Seung‐Man Park South Korea 10 189 0.6× 316 1.2× 25 0.3× 42 0.9× 170 5.9× 17 396
J S Aldrete United States 9 256 0.9× 138 0.5× 60 0.8× 19 0.4× 43 1.5× 14 312
Souichi Nakagawa Japan 10 313 1.1× 300 1.2× 19 0.2× 21 0.5× 72 2.5× 17 388
Kheng Tian Lim Ireland 9 217 0.7× 177 0.7× 15 0.2× 65 1.4× 97 3.3× 25 308
John Baillie United States 8 279 0.9× 172 0.7× 35 0.5× 53 1.2× 95 3.3× 16 335
Victor F. Trastek United States 9 254 0.9× 259 1.0× 31 0.4× 25 0.5× 80 2.8× 11 386
José Luis Salvador-Sanchís Spain 10 212 0.7× 175 0.7× 15 0.2× 71 1.5× 63 2.2× 44 339
Claude Avisse France 9 177 0.6× 64 0.3× 14 0.2× 60 1.3× 23 0.8× 19 215

Countries citing papers authored by E. Bollschweiler

Since Specialization
Citations

This map shows the geographic impact of E. Bollschweiler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Bollschweiler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Bollschweiler more than expected).

Fields of papers citing papers by E. Bollschweiler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Bollschweiler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Bollschweiler. The network helps show where E. Bollschweiler may publish in the future.

Co-authorship network of co-authors of E. Bollschweiler

This figure shows the co-authorship network connecting the top 25 collaborators of E. Bollschweiler. A scholar is included among the top collaborators of E. Bollschweiler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Bollschweiler. E. Bollschweiler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Favi, Francesco, E. Bollschweiler, Felix Berlth, et al.. (2017). Neoadjuvant chemotherapy or chemoradiation for patients with advanced adenocarcinoma of the oesophagus? A propensity score-matched study. European Journal of Surgical Oncology. 43(8). 1572–1580. 22 indexed citations
2.
Berlth, Felix, Patrick Sven Plum, Seung‐Hun Chon, et al.. (2017). Impact of the Weekday of Surgery on Outcome in Gastric Cancer Patients who Underwent D2‐Gastrectomy. World Journal of Surgery. 42(6). 1811–1818. 12 indexed citations
3.
Hölscher, Arnulf H., Uta Drebber, Henner Schmidt, & E. Bollschweiler. (2014). Prognostic Classification of Histopathologic Response to Neoadjuvant Therapy in Esophageal Adenocarcinoma. Annals of Surgery. 260(5). 779–785. 47 indexed citations
4.
Siewert, J. R., et al.. (2009). TNM-Klassifikation bei Magenkarzinom – das Problem der T2-Tumoren. DMW - Deutsche Medizinische Wochenschrift. 116(12). 473–475.
5.
Brabender, Jan, et al.. (2009). HIF-1α protein expression is associated with the environmental inflammatory reaction in Barrett's metaplasia. Diseases of the Esophagus. 22(8). 694–699. 17 indexed citations
6.
Vallböhmer, Daniel, A. H. Hölscher, M. Hölscher, et al.. (2009). Options in the management of esophageal perforation: analysis over a 12-year period. Diseases of the Esophagus. 23(3). 185–190. 112 indexed citations
7.
Bollschweiler, E., Ralf Metzger, Uta Drebber, et al.. (2008). Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis. Annals of Oncology. 20(2). 231–238. 83 indexed citations
8.
Vallböhmer, Daniel, A. H. Hölscher, Michael Schmidt, et al.. (2008). Limitations of positron emission tomography in predicting histopathologic response or prognosis following neoadjuvant chemoradiation for esophageal cancer. Journal of Clinical Oncology. 26(15_suppl). 4529–4529. 2 indexed citations
9.
Baldus, Stephan, Haitao Xi, Jan Brabender, et al.. (2007). Association of COX‐2 expression with corresponding active and chronic inflammatory reactions in Barrett's metaplasia and progression to cancer. Histopathology. 50(2). 203–209. 15 indexed citations
10.
Bollschweiler, E., et al.. (2007). Chirurgie des Magenkarzinoms - Qualitätssicherung. 42(2). 82–88. 1 indexed citations
11.
Mönig, Stefan, E. Bollschweiler, & A. H. Hölscher. (2005). Stellenwert der Lymphadenektomie im Behandlungskonzept des Magenkarzinoms. 40(4). 272–278. 1 indexed citations
12.
Hölscher, Arnulf H., et al.. (2004). Gastro�sophageale Refluxkrankheit. Der Chirurg. 76(4). 345–352. 1 indexed citations
13.
Bollschweiler, E., Paul M. Schneider, Stefan Mönig, et al.. (2003). Prognoserelevanz von biologischen und molekularen Markern in der Onkologie. Der Chirurg. 74(2). 139–144. 3 indexed citations
14.
Gutschow, Christian A., et al.. (2001). [Conventional surgery in peptic ulcer perforation: indications and procedure].. PubMed. 118. 285–8. 2 indexed citations
15.
16.
Schrappe, Matthias, et al.. (1999). [The Cologne Guidelines Conference: computer-assisted clinical practice guidelines in clinical diagnosis].. PubMed. 93(6). 447–53. 1 indexed citations
17.
Siewert, et al.. (1990). [Changes in the frequency of interventions in general surgery].. PubMed. 61(12). 855–63. 9 indexed citations
18.
Schäfer, Karl‐Herbert, et al.. (1989). Immunosuppressive activities of cyclosporine metabolites M17 and M21 within a bioassay based on inhibition of interleukin-2 production.. PubMed. 21(1 Pt 1). 839–839. 4 indexed citations
19.
Florack, G., et al.. (1988). Biologic assessment of cyclosporine in serum of kidney transplant patients.. PubMed. 20(2 Suppl 2). 494–8. 1 indexed citations
20.
Florack, G., et al.. (1987). Measurement of cyclosporine bioactivity in serum of renal transplant recipients: development and comparison with RIA.. PubMed. 19(1 Pt 2). 1734–6. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marta Bini Breakdown of academic impact, for papers by In Seok Choi Breakdown of academic impact, for papers by Seung‐Man Park Breakdown of academic impact, for papers by J S Aldrete Breakdown of academic impact, for papers by Souichi Nakagawa Breakdown of academic impact, for papers by Kheng Tian Lim Breakdown of academic impact, for papers by John Baillie Breakdown of academic impact, for papers by Victor F. Trastek Breakdown of academic impact, for papers by José Luis Salvador-Sanchís Breakdown of academic impact, for papers by Claude Avisse
Rankless by CCL
2026